Inter Parfums
This article was originally published in The Rose Sheet
Executive Summary
Purchase of Tristar fragrances may provide opportunity to expand distribution of mass market brands into Wal-Mart, CEO Jean Madar says during Q1 sales and earnings release May 14. Firm's wholly-owned subsidiary recently received approval of purchase from San Antonio Bankruptcy Court and expects to close definitive agreement by end of the month (1"The Rose Sheet" May 6, 2002, In Brief). Inter Parfums mass market sales increased 9% on strong performances by Aziza and Intimate health and beauty aids, while prestige fragrances were down 10% in constant dollars, reflecting fewer launches compared with same period last year. Net sales declined 8.5% to $28.4 mil. and net income fell 1% to $2 mil...You may also be interested in...
Inter Parfums buy
Impella Safety Update: Data Supports Pump For Qualified Patients
Updated data from a postmarket study of Abiomed’s Impella RP right-heart pump further supports the device’s safety for a specific patient population.
Quality, Safety, MDSAP A Focus For Medtech In New USMCA Trade Agreement
The new US-Mexico-Canada (USMCA) trade agreement includes language on enhancing regulatory compatibility between the three countries by recognizing quality systems audits performed under the Medical Device Single Audit Program (MDSAP). It also stipulates that each trading partner “consider its resources and technical capacity” in ensuring the safety, effectiveness and quality of devices – and more. Medtech industry advocacy group AdvaMed is praising the deal, reached by the three countries on 10 December.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: